myPath Melanoma

myPath® Melanoma is a clinically validated molecular test designed to objectively differentiate malignant melanoma from benign nevi w/ a high degree of accuracy

[myPath Melanoma @myPathMelanoma]

Nevus or Melanoma? In second case study, Dr. Clarke discusses the lesion at clinical, histopathological and molecular level. He addresses questions that arise pertaining to myPath® test as well as the results. Watch here: https://t.co/YoctzDg0Hn #Melanoma #DermPath #Dermatology

[myPath Melanoma @myPathMelanoma]

Using RT-qPCR technology, myPath Melanoma objectively distinguished melanoma from benign nevi with greater than 90% accuracy in three independent clinical validation studies. READ MORE: https://t.co/UnJKEV8I0n #Melanoma #myPathMelanoma #Dermatology #DermPath

[myPath Melanoma @myPathMelanoma]

Can a gene expression signature detect all of the different types of melanoma? Dr. Loren Clarke answers this question in a short video. https://t.co/iGqaMF7h92

#myPathMelanoma #Melanoma #Dermatology

[myPath Melanoma @myPathMelanoma]

myPath Melanoma testing can result in an 80% reduction in biopsy site re-excisions for lesions that receive a benign test result. READ THE STUDY OVERVIEW: https://t.co/J0s6OQGTCG

#myPathMelanoma #Melanoma #BenignNevi #Dermatology

[myPath Melanoma @myPathMelanoma]

Two published clinical utility studies show that myPath® Melanoma directly impacts patient care by increasing the likelihood of a definitive diagnosis and guiding the choice of treatment. https://t.co/GRfigJT5AP #Melanoma #SkinCancer#Dermatology #myPathMelanoma

[myPath Melanoma @myPathMelanoma]

Learn more about the stages of melanoma including Breslow Depth, regional spread, and metastases.

https://t.co/D3uvUZQ91P

#Melanoma #MelanomaStages #SkinCancer #Dermatology #Dermatologist

[myPath Melanoma @myPathMelanoma]

Can a gene expression signature detect all of the different types of melanoma? Dr. Loren Clarke answers this question in a short video. https://t.co/AbjhXO0tlz #myPathMelanoma #Melanoma #Dermatology

[myPath Melanoma @myPathMelanoma]

Nevus or Melanoma? In second case study, Dr. Clarke discusses the lesion at clinical, histopathological and molecular level. He addresses questions that arise pertaining to myPath® test as well as the results. Watch here: https://t.co/rpCN9HRKkC #Melanoma #DermPath #Dermatology

[myPath Melanoma @myPathMelanoma]

Ordering a myPath® Melanoma test is quick and easy. With an average turn-around-time of 5-7 days and only 4 steps for sample submissions you can get a definitive answer for ambiguous lesions quickly. https://t.co/DeCpcauUAS #myPathMelanoma #Melanoma #MelanomaTesting #Dermatology

[myPath Melanoma @myPathMelanoma]

Have a question? Contact our dedicated myPath® Melanoma customer service team today at [phone]

#myPathMelanoma #Melanoma #Dermatology #SkinCancer

[myPath Melanoma @myPathMelanoma]

Want to see examples of myPath® Melanoma in action? We have several relevant case studies showcasing benign and malignant test results. https://t.co/7I47cVikdb #CaseStudy #MelanomaTesting #Melanoma #SkinCancer #myPathMelanoma

[myPath Melanoma @myPathMelanoma]

Two published clinical utility studies show that myPath® Melanoma directly impacts patient care by increasing the likelihood of a definitive diagnosis and guiding the choice of treatment. https://t.co/1nlCDBNKi0

#Melanoma #SkinCancer#Dermatology #myPathMelanoma

[myPath Melanoma @myPathMelanoma]

Melanoma or just a nevus? Take a look at this case study and test your knowledge! https://t.co/S0PuhZPP0K #CaseStudy #Melanoma #MelanomaTesting #Dermatology #SkinCancer

[myPath Melanoma @myPathMelanoma]

Do you have a suspicious mole? Review your ABCDE's of skin cancer and make an appointment to see your dermatologist. https://t.co/3SihGlqie2

#Melanoma #SkinCancer #Dermatology

[myPath Melanoma @myPathMelanoma]

Ordering a myPath® Melanoma test is quick and easy. With an average turn-around-time of 5-7 days and only 4 steps for sample submissions you can get a definitive answer for ambiguous lesions quickly. https://t.co/ZiVGjmD3gV #myPathMelanoma #Melanoma #MelanomaTesting #Dermatology

[myPath Melanoma @myPathMelanoma]

The myPath Melanoma test measures 23 genes for which expression patterns differ between malignant melanoma and benign nevi. These genes are involved in cell differentiation, cell signaling, and immune response signaling. https://t.co/9qJPfpg2q7 #Melanoma

[myPath Melanoma @myPathMelanoma]

"What do you mean you can't tell if it's #melanoma?" Uncertain diagnoses can be frustrating for both patients and physicians, but not all melanocytic neoplasms can be diagnosed definitively by histopathology alone. How can myPath Melanoma help? Click: https://t.co/ZHkGZGzKfU

[myPath Melanoma @myPathMelanoma]

myPath® Melanoma reports are simple and easy to interpret. The test generates a single numerical score that classifies a melanocytic lesion as ‘likely benign’, ‘likely malignant’, or ‘indeterminate'. https://t.co/idefetfe3I #Melanoma #SkinCancer #myPathMelanoma #Dermatology

[myPath Melanoma @myPathMelanoma]

Using RT-qPCR technology, myPath Melanoma objectively distinguished melanoma from benign nevi with greater than 90% accuracy in three independent clinical validation studies. READ MORE: https://t.co/F8otMZwOGv

#Melanoma #myPathMelanoma #Dermatology #DermPath

[myPath Melanoma @myPathMelanoma]

Learn more about the stages of melanoma including Breslow Depth, regional spread, and metastases.

https://t.co/XQLEXCd29w

#Melanoma #MelanomaStages #SkinCancer #Dermatology #Dermatologist